Bernard Le Foll
Behavioral Neuroscience Research Branch
National Institute on Drug Abuse
National Institutes of Health
Department of Health and Human Services
USA
Name/email consistency: high
- Nicotine as a typical drug of abuse in experimental animals and humans. Le Foll, B., Goldberg, S.R. Psychopharmacology (Berl.) (2006)
- Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Delta-9-tetrahydrocannabinol in rats. Le Foll, B., Wiggins, M., Goldberg, S.R. Behav. Pharmacol (2006)
- Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. Le Foll, B., Goldberg, S.R. J. Pharmacol. Exp. Ther. (2005)
- Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Le Foll, B., Sokoloff, P., Stark, H., Goldberg, S.R. Neuropsychopharmacology (2005)
- Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Le Foll, B., Diaz, J., Sokoloff, P. Life Sci. (2005)
- A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Le Foll, B., Diaz, J., Sokoloff, P. Neuroreport (2005)
- Nicotine induces conditioned place preferences over a large range of doses in rats. Le Foll, B., Goldberg, S.R. Psychopharmacology (Berl.) (2005)
- Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans. Le Foll, B., Goldberg, S.R. Trends Pharmacol. Sci. (2005)
- The dopamine D3 receptor and drug dependence: effects on reward or beyond?. Le Foll, B., Goldberg, S.R., Sokoloff, P. Neuropharmacology (2005)
- Ethanol does not affect discriminative-stimulus effects of nicotine in rats. Le Foll, B., Goldberg, S.R. Eur. J. Pharmacol. (2005)
- Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Le Foll, B., Goldberg, S.R. Neuroreport (2004)